Updated European Screening Tool and New Available Research
WEBSITE NEWS: European Content
The European Screening Decision Support Tool has just been updated. The tool represents a screening protocol to optimize cancer detection; individual countries vary in screening guidelines, available technologies, and informing women of breast density. Please see the European Screening Guidelines map for country-specific information.
New Research Article
AI evaluation of the mammogram alone may identify women at high risk better than risk models based on family history, biopsies, and/or genetic testing. In the study by Yala et al, Mirai, a risk model developed at MGH to assess breast cancer risk from screening mammograms, more accurately identified high-risk patients than the Tyrer-Cuzick v8 risk model and prior deep learning models. Mirai identified 41.5% of women developing breast cancer in the next five years as high-risk, compared to only 22.9% with the Tyrer-Cuzick model v8. Mirai performed similarly across all density categories. (Yala A, Mikhael PG, Strand F, et al. Toward robust mammography-based models for breast cancer risk. Sci Transl Med. 2021;13(578):eaba4373. doi: 10.1126/scitranslmed.aba4373)